BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
 

New 2-D Gel Scanner Guarantees Unbeatable Spot Detection

 

11.03.05 Cambridge, UK: Syngene, a world-leading manufacturer of image analysis solutions, is delighted to introduce its new ProteomeScan high-resolution image scanner. This user-friendly system, which can generate high-quality 2-D gel images in seconds, is ideal for scientists looking for unrivalled accuracy in their proteomics research.

The ProteomeScan is controlled by icon driven software and allows users to dictate the kind of image they would like by selecting scanning resolution, compression and scan speed. The system can generate images of up to 12,800 x 12,800-dpi max output resolution, ensuring that even the smallest protein spots are detected.

For scientists wanting to save time with their 2-D gel analysis, the ProteomeScan has been designed to transfer images directly into DYMENSION, Syngene’s revolutionary new 2-D image analysis software. DYMENSION can analyse a typical 2-D gel image in seconds rather than the normal minutes or hours other available software takes to perform this task, making it a perfect partner for ProteomeScan.

The flexible ProteomeScan can also switch between transmittance and reflectance modes and has variable colour scanning, which means it is easy to scan a variety of different gel stains such as silver, Coomassie blue and Sypro Ruby. Safety is a priority and the system is fully sealed to protect against leaks of liquid from wet gels.

There are two versions of ProteomeScan available. The ProteomeScan A4 Pro can image gels up to 21 cm x 29 cm, whereas a ProteomeScan A3 Pro is an alternative for users needing to scan larger gels, as it can image an area of 31 cm x 43 cm.

Laura Sullivan, Syngene’s Divisional Manager stated: “We are excited by the excellent performance of our new ProteomeScan. It perfectly complements our exceptional DYMENSION 2-D analysis software, to provide an unbeatable package for generating rapid, yet accurate results in proteomics research.”


 

-Ends-


Sypro is a trademark of Molecular Probes Inc.

For Further Information Contact:
Jayne Arthur, Syngene, Beacon House, Nuffield Road, Cambridge, CB4 1TF, UK.
Tel: +44(0) 1223-727123 Fax +44 (0) 1223-727101
Email: jayne.arthur@2dymension.com  Web site: www.2dymension.com  

Editor Contact:
Dr Sue Pearson, PO Box 170, Hitchin, Hertfordshire SG5 3GD, UK.
Tel/Fax + (0) 44 1462- 635327 Email: sue6.pearson@ntlworld.com

Note to Editors

About Syngene


Syngene is a world-leading supplier of integrated imaging solutions for analysis and documentation of gel-based information. Syngene’s systems are used by more than 10,000 research organisations and over 50,000 individual scientists world-wide and include many of the world’s top pharmaceutical companies and major research institutes.

Syngene, founded in 1997 is a division of the Synoptics Group based in Cambridge, UK. The Group’s other divisions, Syncroscopy and Synbiosis, specialise in digital imaging solutions for microscopy and microbial applications respectively. Synoptics currently employs 60 people in its UK and subsidiary operation in Frederick, USA. The Group has profitable revenue of almost $10 million and continues to grow rapidly.


 

 
 

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.